These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31300028)

  • 1. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
    Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
    Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial.
    Moriarty AS; Louwagie GM; Mdege ND; Morojele N; Tumbo J; Omole OB; Bachmann MO; Kanaan M; Turner A; Parrott S; Siddiqi K; Ayo-Yusuf OA
    Trials; 2019 Jul; 20(1):457. PubMed ID: 31349850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
    Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
    J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
    Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
    Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. People-centered tuberculosis care versus standard directly observed therapy: study protocol for a cluster randomized controlled trial.
    Khachadourian V; Truzyan N; Harutyunyan A; Thompson ME; Harutyunyan T; Petrosyan V
    Trials; 2015 Jun; 16():281. PubMed ID: 26093675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study.
    Bediang G; Stoll B; Elia N; Abena JL; Nolna D; Chastonay P; Geissbuhler A
    Trials; 2014 Jan; 15():35. PubMed ID: 24460827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
    Trials; 2020 May; 21(1):383. PubMed ID: 32370774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a customized digital adherence tool on retention in care and adherence to antiretroviral treatment in breastfeeding women, children and adolescents living with HIV in Tanzania: a mixed-methods study followed by clinical trials.
    Sumari-de Boer IM; Ngowi KM; Swai IU; Masika LV; Maro RA; Mtenga AE; Mtesha BA; Nieuwkerk PT; Reis R; de Wit TFR; Aarnoutse RE
    Trials; 2023 Apr; 24(1):285. PubMed ID: 37085913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
    Maraba N; Orrell C; Chetty-Makkan CM; Velen K; Mukora R; Page-Shipp L; Naidoo P; Mbatha MT; Fielding KL; Charalambous S
    Trials; 2021 Jun; 22(1):389. PubMed ID: 34108036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
    Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
    PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Adherence Technologies Linked to Mobile Money Incentives for Medication Adherence Among People Living With Tuberculosis: Mixed Methods Feasibility and Acceptability Study.
    Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
    JMIR Hum Factors; 2024 May; 11():e47996. PubMed ID: 38819905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet.
    Wei X; Hicks JP; Pasang P; Zhang Z; Haldane V; Liu X; Yin T; Wang L; Shi D; Ge S; Walley J; Upshur R; Hu J
    Trials; 2019 May; 20(1):273. PubMed ID: 31097023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.
    Sahile Z; Perimal-Lewis L; Arbon P; Maeder AJ
    PLoS One; 2021; 16(12):e0261758. PubMed ID: 34972128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Digital Adherence Tools on Adherence to Antiretroviral Treatment Among Adults Living With HIV in Kilimanjaro, Tanzania: A Randomized Controlled Trial.
    Sumari-de Boer IM; Ngowi KM; Sonda TB; Pima FM; Masika Bpharm LV; Sprangers MAG; Reiss P; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1136-1144. PubMed ID: 33871411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
    Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
    BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Marconi VC
    BMC Med; 2022 Sep; 20(1):310. PubMed ID: 36167528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
    Kamal AK; Muqeet A; Farhat K; Khalid W; Jamil A; Gowani A; Muhammad AA; Zaidi F; Khan D; Elahi T; Sharif S; Raz S; Zafar T; Bokhari SS; Rahman N; Sultan FA; Sayani S; Virani SS
    Trials; 2016 Mar; 17(1):121. PubMed ID: 26944938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial.
    Bediang G; Stoll B; Elia N; Abena JL; Geissbuhler A
    BMC Public Health; 2018 May; 18(1):583. PubMed ID: 29720146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bracelet- and self-directed observational therapy for control of tuberculosis: study protocol for a cluster randomized controlled trial.
    Huang R; Ren G; Hu J
    Trials; 2017 Jul; 18(1):286. PubMed ID: 28673323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial.
    Lewis JJ; Liu X; Zhang Z; Thomas BV; Vassall A; Sweeney S; Caihong X; Dongmei H; Xue L; Yongxin G; Huan S; Shiwen J; Fielding KL
    Trials; 2018 Jul; 19(1):398. PubMed ID: 30045757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.